ENHANCED SENSITIVITY TO NEUTRALIZING ANTIBODIES IN A VARIANT OF EQUINE INFECTIOUS-ANEMIA VIRUS IS LINKED TO AMINO-ACID SUBSTITUTIONS IN THE SURFACE UNIT ENVELOPE GLYCOPROTEIN

被引:32
作者
COOK, RF
BERGER, SL
RUSHLOW, KE
MCMANUS, JM
COOK, SJ
HARROLD, S
RAABE, ML
MONTELARO, RC
ISSEL, CJ
机构
[1] UNIV KENTUCKY,GLUCK EQUINE RES CTR 108,DEPT VET SCI,LEXINGTON,KY 40546
[2] UNIV PITTSBURGH,SCH MED,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15261
[3] PARAVAX INC,FT COLLINS,CO 80526
关键词
D O I
10.1128/JVI.69.3.1493-1499.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Serial passage of the prototype (PR) cell-adapted Wyoming strain of equine infectious anemia virus (EIAV) in fetal donkey dermal (FDD) rather than fetal horse (designated fetal equine kidney [FEK]) cell cultures resulted in the generation of a variant virus strain which produced accelerated cytopathic effects in FDD cells and was 100- to 1,000-fold more sensitive to neutralizing antibodies than its parent. This neutralization-sensitive variant was designated the FDD strain. Although there were differences in glycosylation between the PR and FDD strains, passage of the FDD virus in FEK cells did not reduce its sensitivity to neutralizing antibody. Nucleotide sequencing of the region encoding the surface unit (SU) protein from the FDD strain revealed nine amino acid substitutions compared with the PR strain. Two of these substitutions resulted in changes in the polarity of charge, four caused the introduction of a charged residue, and three had no net change in charge. Nucleotide sequence analysis was extended to the region of the FDD virus genome encoding the extracellular domain of the transmembrane envelope glycoprotein (TM). Unlike the situation with the FDD virus coding region, there were minor variations in nucleotide sequence between individual molecular clones containing this region of the TM gene. Although each clone contained three nucleotide substitutions compared with the PR strain, only one of these was common to all, and this did not affect the amino acid content, Of the remaining two nucleotide substitutions, only one resulted in an amino acid change, and in each case, this change appeared to be conservative. To determine if amino acid substitutions in the SU protein of FDD cell-grown viruses were responsible for the enhanced sensitivity to neutralizing antibodies, chimeric viruses were constructed by using an infectious molecular clone of EIAV. These chimeric viruses contained all of the amino acid substitutions found in the FDD virus strain and were significantly more sensitive to neutralizing antibodies than viruses from the parental (PR) molecular clone. These results demonstrated that sensitivity to neutralizing antibodies in EIAV can be conferred by amino acid residues in the SU protein, However, such amino acid substitutions were not sufficient to enhance cytopathogenicity, as the chimeric viruses did not cause excessive degenerative effects in FDD cells, as was observed with the parental FDD virus strain.
引用
收藏
页码:1493 / 1499
页数:7
相关论文
共 57 条
[1]   NEUTRALIZING ANTIBODIES AGAINST 2 HIV-1 STRAINS IN CONSECUTIVELY COLLECTED SERUM SAMPLES - CROSS NEUTRALIZATION AND ASSOCIATION TO HIV-1 RELATED DISEASE [J].
ARENDRUP, M ;
NIELSEN, CM ;
HANSEN, JES ;
MATHIESEN, LR ;
LINDHARDT, BO ;
SCHEIBEL, E ;
NIELSEN, JO .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (01) :21-28
[2]   MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES [J].
BACK, NKT ;
SMIT, L ;
SCHUTTEN, M ;
NARA, PL ;
TERSMETTE, M ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1993, 67 (11) :6897-6902
[3]   DETAILED MAPPING OF THE ANTIGENICITY OF THE SURFACE UNIT GLYCOPROTEIN OF EQUINE INFECTIOUS-ANEMIA VIRUS BY USING SYNTHETIC PEPTIDE STRATEGIES [J].
BALL, JM ;
RUSHLOW, KE ;
ISSEL, CJ ;
MONTELARO, RC .
JOURNAL OF VIROLOGY, 1992, 66 (02) :732-742
[4]  
Barnett D., 1972, Proceedings of the United States Animal Health Association, V76, P231
[5]  
BIGON C, 1992, BIOTECHNIQUES, V13, P194
[6]   COMPARISON BETWEEN INVITRO NEUTRALIZATION TITERS AND INVIVO PROTECTION AGAINST HOMOLOGOUS AND HETEROLOGOUS CHALLENGE INDUCED BY VACCINES PREPARED FROM 2 SEROLOGICALLY DISTINCT VARIANTS OF FOOT-AND-MOUTH-DISEASE VIRUS, SEROTYPE-A22 [J].
BOLWELL, C ;
PARRY, NR ;
ROWLANDS, DJ .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :727-731
[7]  
CHEN CA, 1988, BIOTECHNIQUES, V6, P632
[8]  
CLABOUGH DL, 1990, VET MED-US, V85, P1007
[9]  
COOK RF, 1992, BIOTECHNIQUES, V13, P380
[10]  
COOK RF, UNPUB